Bazevita Tablet
Bazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
BIS Pharmaceuticals Co., Ltd.
MFDS item code 201900707 · Approved 2019.01.29
This product's status changed to Expired on 2024.01.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used to treat and prevent osteoporosis in postmenopausal women. It is particularly effective in reducing the incidence of spinal fractures. However, the efficacy on non-vertebral fractures has not been clearly established, thus caution is needed. This medication can improve bone health and reduce fracture risk.
Take 1 tablet once daily, with or without food. If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.
This medication may increase the risk of venous thromboembolism, such as deep vein thrombosis or pulmonary embolism. The risk is highest in the first year of treatment, so women at high risk for thrombosis should avoid taking this medication. This medication is intended for postmenopausal women only, and its safety has not been established in premenopausal women, hence it is not recommended. Additionally, while it does not induce endometrial hyperplasia, if uterine bleeding occurs during use, it is essential to consult a healthcare professional. The safety of this medication in breast cancer patients has not been sufficiently studied, so it is best not to use it for the prevention or treatment of breast cancer. This medication should not be administered to patients with a history of hypersensitivity or thrombosis, pregnant women or those who may become pregnant, breastfeeding women, patients with unexplained uterine bleeding, symptoms of endometrial cancer, hypercalcemia, hypercalciuria, or kidney stones. Also, this medication contains lactose, so individuals with certain genetic lactose intolerance should not take it. Patients with hypertriglyceridemia, renal or liver function impairment, limited movement, or those taking certain medications should use this medication cautiously and consult their physician if necessary. During treatment, symptoms such as flushing due to vasodilation or leg cramps may occur, and rare adverse reactions such as thrombosis, retinal vein thrombosis, dry mouth, and skin rashes have been reported. If any eye symptoms occur, notify healthcare personnel immediately. This medication is best taken with calcium supplements if calcium intake is insufficient and may require additional vitamin D supplementation for patients at high risk of vitamin D deficiency. Caution is needed while driving or operating machinery due to the potential for drowsiness or visual disturbances. In case of overdose, there are no specific antidotes, and symptomatic treatment should be provided. Excessive intake of vitamin D may increase blood calcium levels, causing various side effects, requiring blood tests and monitoring. This medication should be kept out of reach of children and stored in its original container to prevent misuse or deterioration of the drug's quality.
Allergic reactions, drowsiness, retinal vein thrombosis, facial flushing, deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, dry mouth, hives, rash, itching, muscle cramps, peripheral edema, increased serum triglycerides, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased vision, blurred vision, photophobia, visual field defect, visual impairment, dry eye syndrome, eyelid edema, eyelid spasms, eye pain, eye swelling, death, fever, generalized edema, fatigue, fractures, myalgia, rotator cuff syndrome, spinal canal stenosis, cerebral infarction, cerebral hemorrhage, bradycardia, respiratory failure, bile duct stones, vomiting, gastritis, colon polyps, belching, allergic reactions, chest discomfort, leg pain, edema, facial swelling, changes in temperature sensation, lethargy, weakness, inadequate effect, dermatitis, localized skin reactions, increased sweating, eczema, hair loss, low back pain, arthralgia, muscle weakness, dizziness, pharyngitis, pyelonephritis, headache, palpitations, upper respiratory infection, retinal hemorrhage, sputum disorders, cough, asthma, shortness of breath, laryngitis, increased alkaline phosphatase, liver cysts, hepatocyte damage, weight gain, hyperlipidemia, central obesity, dysuria, abnormal urine, renal cysts, urinary incontinence, vaginal bleeding, breast congestion, insomnia, leukocytosis, laceration, contusion, psychological symptoms, consciousness disturbance, headache, nausea, vomiting, loss of appetite, weight loss, increased thirst, arrhythmia, increased urge to urinate, kidney stones, renal calcification, calcification in the peripheral tissues of the bone, myalgia, arthralgia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the efficacy of the medication for a longer period.
Pink oblong film-coated tablet
28 tablets (28 tablets/PTP)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Bazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
BIS Pharmaceuticals Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
DaeHwa Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hyouns Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.